NASDAQ · Analyst Forecast

Creative Medical Technology Holdings, Inc. (CELZ) Stock Forecast & Price Target

$0.47 NASDAQ: CELZ Market Cap $3.54M

Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 19, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Creative Medical Technology Holdings, Inc. (CELZ), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Creative Medical Technology Holdings, Inc., analysts forecast revenue rising from $3,000 in 2025 to $108.68M in 2030; the average estimate for 2030 earnings per share is $3.39; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$3,000$3,000$3,0001
2026$23.41M$23.41M$23.41M1
2027$33.83M$33.83M$33.83M1
2028$60.08M$60.08M$60.08M1
2029$85.25M$85.25M$85.25M1
2030$108.68M$108.68M$108.68M1

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$2.04−$2.04−$2.041
2026−$1.56−$1.56−$1.561
2027−$1.09−$1.09−$1.091
2028−$1.05−$1.05−$1.051
2029$2.92$2.92$2.921
2030$3.39$3.39$3.391

Creative Medical Technology Holdings, Inc. (CELZ) forecast — frequently asked questions

What are analysts forecasting for Creative Medical Technology Holdings, Inc.'s earnings?

The average analyst estimate for Creative Medical Technology Holdings, Inc. (CELZ) earnings per share in 2030 is 3.39, with individual estimates between 3.39 and 3.39.

How much revenue is Creative Medical Technology Holdings, Inc. expected to make?

Analysts forecast Creative Medical Technology Holdings, Inc. (CELZ) revenue of $108.68M in 2030, based on 1 published estimates.

How many analysts cover CELZ?

1 analyst contribute estimates for Creative Medical Technology Holdings, Inc. (CELZ). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.